Mangoceuticals Inc
NASDAQ:MGRX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.235
12.45
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MGRX stock under the Base Case scenario is 0.38 USD. Compared to the current market price of 2.65 USD, Mangoceuticals Inc is Overvalued by 86%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Mangoceuticals Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MGRX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Mangoceuticals Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Mangoceuticals Inc
Balance Sheet Decomposition
Mangoceuticals Inc
Current Assets | 517.6k |
Cash & Short-Term Investments | 490.2k |
Other Current Assets | 27.3k |
Non-Current Assets | 14.7m |
PP&E | 93.3k |
Intangibles | 14.6m |
Other Non-Current Assets | 17k |
Current Liabilities | 1.4m |
Accounts Payable | 718.7k |
Accrued Liabilities | 72.1k |
Short-Term Debt | 187.5k |
Other Current Liabilities | 400k |
Non-Current Liabilities | 29.7k |
Other Non-Current Liabilities | 29.7k |
Earnings Waterfall
Mangoceuticals Inc
Revenue
|
866.8k
USD
|
Cost of Revenue
|
-362.4k
USD
|
Gross Profit
|
504.4k
USD
|
Operating Expenses
|
-9.4m
USD
|
Operating Income
|
-8.9m
USD
|
Other Expenses
|
-222.3k
USD
|
Net Income
|
-9.1m
USD
|
Free Cash Flow Analysis
Mangoceuticals Inc
USD | |
Free Cash Flow | USD |
MGRX Profitability Score
Profitability Due Diligence
Mangoceuticals Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Mangoceuticals Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
MGRX Solvency Score
Solvency Due Diligence
Mangoceuticals Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Score
Mangoceuticals Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MGRX Price Targets Summary
Mangoceuticals Inc
Dividends
Current shareholder yield for MGRX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
MGRX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.
Contact
IPO
Employees
Officers
The intrinsic value of one MGRX stock under the Base Case scenario is 0.38 USD.
Compared to the current market price of 2.65 USD, Mangoceuticals Inc is Overvalued by 86%.